Plasma and Serum Proteomics Analysis Service Market Report – Research, Industry Analysis Reports and Market Demands

Global Plasma and Serum Proteomics Analysis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Plasma and Serum Proteomics Analysis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Plasma and Serum Proteomics Analysis Service by Company Revenue
- 3.2.2 Top 3 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
- 3.2.3 Top 6 Plasma and Serum Proteomics Analysis Service Players Market Share in 2025
3.3 Plasma and Serum Proteomics Analysis Service Market: Overall Company Footprint Analysis
- 3.3.1 Plasma and Serum Proteomics Analysis Service Market: Region Footprint
- 3.3.2 Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
- 3.3.3 Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Plasma and Serum Proteomics Analysis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Plasma and Serum Proteomics Analysis Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Plasma and Serum Proteomics Analysis Service Market Forecast by Application (2027-2032)

6 North America

6.1 North America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
6.2 North America Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2032)
6.3 North America Plasma and Serum Proteomics Analysis Service Market Size by Country
- 6.3.1 North America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
- 6.3.2 United States Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 6.3.3 Canada Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
7.2 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
7.3 Europe Plasma and Serum Proteomics Analysis Service Market Size by Country
- 7.3.1 Europe Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
- 7.3.2 Germany Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 7.3.3 France Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 7.3.5 Russia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 7.3.6 Italy Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Plasma and Serum Proteomics Analysis Service Market Size by Region
- 8.3.1 Asia-Pacific Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2032)
- 8.3.2 China Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 8.3.3 Japan Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 8.3.5 India Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 8.3.7 Australia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)

9 South America

9.1 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
9.2 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
9.3 South America Plasma and Serum Proteomics Analysis Service Market Size by Country
- 9.3.1 South America Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Plasma and Serum Proteomics Analysis Service Market Size by Country
- 10.3.1 Middle East & Africa Plasma and Serum Proteomics Analysis Service Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)
- 10.3.4 UAE Plasma and Serum Proteomics Analysis Service Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Plasma and Serum Proteomics Analysis Service Market Drivers
11.2 Plasma and Serum Proteomics Analysis Service Market Restraints
11.3 Plasma and Serum Proteomics Analysis Service Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Plasma and Serum Proteomics Analysis Service Industry Chain
12.2 Plasma and Serum Proteomics Analysis Service Upstream Analysis
12.3 Plasma and Serum Proteomics Analysis Service Midstream Analysis
12.4 Plasma and Serum Proteomics Analysis Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Plasma and Serum Proteomics Analysis Service market size was valued at US$ 769 million in 2025 and is forecast to a readjusted size of US$ 1651 million by 2032 with a CAGR of 11.8% during review period.
Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
This report is a detailed and comprehensive analysis for global Plasma and Serum Proteomics Analysis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Plasma and Serum Proteomics Analysis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Plasma and Serum Proteomics Analysis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Plasma and Serum Proteomics Analysis Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Plasma and Serum Proteomics Analysis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Plasma and Serum Proteomics Analysis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plasma Proteomics Analysis Service
Serum Proteomics Analysis Service
Market segment by End User
Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others
Market segment by Research Areas
Oncology
Cardiovascular
Agriculture
Neuroscience
Other
Market segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Market segment by players, this report covers
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Plasma and Serum Proteomics Analysis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Plasma and Serum Proteomics Analysis Service, with revenue, gross margin, and global market share of Plasma and Serum Proteomics Analysis Service from 2021 to 2026.
Chapter 3, the Plasma and Serum Proteomics Analysis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Plasma and Serum Proteomics Analysis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma and Serum Proteomics Analysis Service.
Chapter 13, to describe Plasma and Serum Proteomics Analysis Service research findings and conclusion.

Buy now